Vilazon-20 Tablet

About Vilazon-20 Tablet

Made by Renata PLC., Vilazon-20 is a tablet whose active ingredient is Vilazodone Hydrochloride. Vilazon-20 is intended for adults with major depressive disorder, a condition where low mood and loss of interest persist and interfere with daily life.

There are 3 brands of Vilazodone Hydrochloride listed in Bangladesh.

What is Vilazon-20 Tablet?

Vilazon-20 comes as a tablet with 20 mg of Vilazodone Hydrochloride, from Renata PLC. It is a prescription medicine, so the decision to start it, the strength used and how long treatment continues all rest with the treating doctor. Doctors use it to treat major depressive disorder in adults. Ask your doctor or pharmacist if you are unsure about it.

Uses of Vilazon-20

Vilazon-20 is intended for adults with major depressive disorder, a condition where low mood and loss of interest persist and interfere with daily life. This is a recognised medical condition in which low mood and related symptoms persist and affect daily life. The tablet is one option a doctor may consider among treatments for this condition. Ask your doctor if you are unsure whether this medicine suits your situation.

How to use Vilazon-20

This tablet is taken by mouth, and the doctor decides the dose and how long you take it. Swallow the tablet with water. Do not attempt to inject it yourself. Do not change the dose or stop on your own, because stopping suddenly can cause problems. Complete the course exactly as prescribed.

Side effects of Vilazon-20

Like all medicines, Vilazon-20 can cause unwanted effects, and the full range is described in the manufacturer's information. Problems that need medical attention include suicidal thoughts or behaviour, serotonin syndrome, increased bleeding risk, activation of mania or hypomania, discontinuation symptoms, seizures, angle-closure glaucoma, low sodium in the blood and sexual dysfunction. Tell your doctor if any side effect bothers you or does not go away. Tell your doctor promptly about any new or worsening symptoms, unusual bleeding, agitation, or eye pain, and seek urgent help if you feel unsafe.

Safety and precautions

People with bipolar disorder, seizures or glaucoma should raise these with the doctor first. If you are pregnant, planning pregnancy or breastfeeding, ask your doctor first; there is a pregnancy registry for antidepressants and little is known about passage into breast milk. Do not take it with monoamine oxidase inhibitors or within the period your doctor advises after stopping them. Tell your doctor if you have bipolar disorder, seizures, glaucoma, or kidney or liver problems.

Frequently asked questions

What does Vilazon-20 treat?

Vilazon-20 is intended for adults with major depressive disorder, a condition where low mood and loss of interest persist and interfere with daily life. This is a recognised medical condition in which low mood and related symptoms persist and affect daily life.

How should I take Vilazon-20?

This tablet is taken by mouth, and the doctor decides the dose and how long you take it. Swallow the tablet with water.

What should I watch for while using Vilazon-20?

Like all medicines, Vilazon-20 can cause unwanted effects, and the full range is described in the manufacturer's information. Problems that need medical attention include suicidal thoughts or behaviour, serotonin syndrome, increased bleeding risk, activation of mania or hypomania, discontinuation symptoms, seizures, angle-closure glaucoma, low sodium in the blood and sexual dysfunction.

Can I use Vilazon-20 in pregnancy or while breastfeeding?

People with bipolar disorder, seizures or glaucoma should raise these with the doctor first. If you are pregnant, planning pregnancy or breastfeeding, ask your doctor first; there is a pregnancy registry for antidepressants and little is known about passage into breast milk.

Indications

Vilazodone Hydrochloride is indicated for the treatment of major depressive disorder (MDD) in adults.

Pharmacology

The mechanism of action of vilazodone in the treatment of major depressive disorder is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through selective inhibition of serotonin reuptake. Vilazodone is also a partial agonist at serotonergic 5-HT1A receptors; however, the net result of this action on serotonergic transmission and its role in vilazodone’s antidepressant effect are unknown.

Dosage & Administration

Dosage for Treatment of Major Depressive Disorder: The recommended target dosage for vilazodone is 20 mg to 40 mg orally once daily with food. To achieve the target dosage, titrate vilazodone as follows:
  • Start with an initial dosage of 10 mg once daily with food for 7 days,
  • Then increase to 20 mg once daily with food.
  • The dose may be increased up to 40 mg once daily with food after a minimum of 7 days between dosage increases.
If a dose is missed, it should be taken as soon as the patient remembers. If it is almost time for the next dose, the patient should skip the missed dose and take the next dose at the regular time. Two doses should not be taken at the same time.

Screen for Bipolar Disorder Prior to Starting vilazodone: Prior to initiating treatment with vilazodone or another antidepressant, screen patients for a personal or family history of bipolar disorder, mania, or hypomania.

Switching to or from a Monoamine Oxidase Inhibitor Antidepressant: At least 14 days must elapse between discontinuation of a monoamine oxidase inhibitor (MAOI) antidepressant and initiation of vilazodone. In addition, at least 14 days must elapse after stopping vilazodone before starting an MAOI antidepressant.

Dosage Adjustments with CYP3A4 Inhibitors or Inducers:
  • Patients receiving concomitant CYP3A4 inhibitors: During concomitant use of a strong CYP3A4 inhibitor (e.g., itraconazole, clarithromycin, voriconazole), the vilazodone dose should not exceed 20 mg once daily. The original vilazodone dose level, can be resumed when the CYP3A4 inhibitor is discontinued.
  • Patients receiving concomitant CYP3A4 inducers: Based on clinical response, consider increasing the dosage of vilazodone by 2-fold, up to a maximum 80 mg once daily, over 1 to 2 weeks in patients taking strong CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin) for greater than 14 days. If CYP3A4 inducers are discontinued, gradually reduce the vilazodone dosage to its original level over 1 to 2 weeks.
Discontinuing Treatment with vilazodone: Adverse reactions may occur upon discontinuation of vilazodone. A gradual reduction in dosage rather than abrupt cessation is recommended whenever possible. vilazodone should be down tapered from the 40 mg once daily dose to 20 mg once daily for 4 days, followed by 10 mg once daily for 3 days. Patients taking vilazodone 20 mg once daily should be tapered to 10 mg once daily for 7 days.

Interaction

CYP3A4 Inhibitors: The vilazodone dose should not exceed 20 mg once daily when coadministered with strong CYP3A4 inhibitors.

CYP3A4 Inducers: Consider increasing vilazodone dosage by 2-fold, up to 80 mg once-daily over 1 to 2 weeks when used concomitantly with strong CYP3A4 inducers for greater than 14 days).

Contraindications

Vilazodone is contraindicated in patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs), including MAOIs such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome.

Side Effects

  • Suicidal Thoughts and Behaviors in Adolescents and Young Adults
  • Serotonin Syndrome
  • Increased Risk of Bleeding
  • Activation of Mania or Hypomania
  • Discontinuation Syndrome
  • Seizures
  • Angle-Closure Glaucoma
  • Hyponatremia
  • Sexual Dysfunction

Pregnancy & Lactation

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. There are no data on the presence of vilazodone in human milk, the effects of vilazodone on the breastfed infant, or the effects of the drug on milk production. 

Precautions & Warnings

Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents (e.g., SSRI, SNRI, triptans, amphetamines), but also when taken alone. If it occurs, discontinue vilazodone and initiate supportive treatment.

Increased Risk of Bleeding: Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other antiplatelet drugs, warfarin, and other anticoagulants may increase this risk.

Activation of Mania/Hypomania: Screen patients for bipolar disorder.

Seizures: Can occur with treatment. Use with caution in patients with a seizure disorder.

Angle Closure Glaucoma: Avoid use of antidepressants, including vilazodone, in patients with untreated anatomically narrow angles.

Sexual Dysfunction: vilazodone may cause symptoms of sexual dysfunction.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Vilazodone Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.